<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Dataset | 南京大学大模型研究协同创新中心</title><link>https://jerry-terrasse.github.io/lm_center_homepage/tags/dataset/</link><atom:link href="https://jerry-terrasse.github.io/lm_center_homepage/tags/dataset/index.xml" rel="self" type="application/rss+xml"/><description>Dataset</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>zh</language><lastBuildDate>Fri, 17 Oct 2025 00:00:00 +0000</lastBuildDate><image><url>https://jerry-terrasse.github.io/lm_center_homepage/media/icon_hu_6873430e16214d30.png</url><title>Dataset</title><link>https://jerry-terrasse.github.io/lm_center_homepage/tags/dataset/</link></image><item><title>【Scientific Data 2025】全球首个多模态AI临床试验预测平台TrialBench正式发布</title><link>https://jerry-terrasse.github.io/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/</link><pubDate>Fri, 17 Oct 2025 00:00:00 +0000</pubDate><guid>https://jerry-terrasse.github.io/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/</guid><description>&lt;p>临床试验是新药从实验室走向患者的关键桥梁，但其过程充满挑战：平均成功率不足15%，耗时超过十年，成本高达数十亿美元。&lt;/p>
&lt;p>2025年9月，由香港科技大学（广州）陈晋泰、南京大学符天凡、哈佛、斯坦福及临床试验公司IQVIA等团队联合开发的&lt;strong>TrialBench平台&lt;/strong>在Nature子刊Scientific Data正式发表，成为全球首个&lt;strong>面向AI的多模态临床试验预测数据集&lt;/strong>。&lt;/p>
&lt;p>
&lt;figure >
&lt;div class="flex justify-center ">
&lt;div class="w-100" >&lt;img alt="图片" srcset="
/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper01_hu_7620d51be21c6fe7.jpg 400w,
/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper01_hu_4aaa86739dc9d05f.jpg 760w,
/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper01_hu_7c2d2d6f553bf2e0.jpg 1200w"
src="https://jerry-terrasse.github.io/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper01_hu_7620d51be21c6fe7.jpg"
width="760"
height="289"
loading="lazy" data-zoomable />&lt;/div>
&lt;/div>&lt;/figure>
&lt;/p>
&lt;h3 id="平台核心价值">平台核心价值&lt;/h3>
&lt;p>TrialBench系统整合了23个子数据集，涵盖8大核心预测任务：&lt;/p>
&lt;ul>
&lt;li>
&lt;p>预测试验时长&lt;/p>
&lt;/li>
&lt;li>
&lt;p>预测患者退出率&lt;/p>
&lt;/li>
&lt;li>
&lt;p>预测严重不良事件&lt;/p>
&lt;/li>
&lt;li>
&lt;p>预测死亡事件&lt;/p>
&lt;/li>
&lt;li>
&lt;p>预测试验是否获批&lt;/p>
&lt;/li>
&lt;li>
&lt;p>识别失败原因&lt;/p>
&lt;/li>
&lt;li>
&lt;p>自动生成入选标准&lt;/p>
&lt;/li>
&lt;li>
&lt;p>推荐合理给药剂量&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>
&lt;figure >
&lt;div class="flex justify-center ">
&lt;div class="w-100" >&lt;img alt="八大临床试验预测问题总结" srcset="
/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper02_hu_4f45e0d23d338d45.jpg 400w,
/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper02_hu_db842f9f42ddfee4.jpg 760w,
/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper02_hu_d70b7ed3870d1439.jpg 1200w"
src="https://jerry-terrasse.github.io/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper02_hu_4f45e0d23d338d45.jpg"
width="760"
height="154"
loading="lazy" data-zoomable />&lt;/div>
&lt;/div>&lt;/figure>
&lt;/p>
&lt;p>八大临床试验预测问题总结&lt;/p>
&lt;h3 id="技术特色">技术特色&lt;/h3>
&lt;p>
&lt;figure >
&lt;div class="flex justify-center ">
&lt;div class="w-100" >&lt;img alt="TrialBench平台技术框架" srcset="
/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper03_hu_39504e77b3020e21.jpg 400w,
/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper03_hu_9e863135d9fea542.jpg 760w,
/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper03_hu_bc88d2be2313038e.jpg 1200w"
src="https://jerry-terrasse.github.io/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper03_hu_39504e77b3020e21.jpg"
width="760"
height="590"
loading="lazy" data-zoomable />&lt;/div>
&lt;/div>&lt;/figure>
&lt;/p>
&lt;p>平台集成了多源数据，采用先进AI技术：&lt;/p>
&lt;ul>
&lt;li>
&lt;p>图神经网络处理药物分子结构&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Bio-BERT解析临床文本&lt;/p>
&lt;/li>
&lt;li>
&lt;p>层级注意力模型理解疾病编码&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>同时提供完整的基线模型、评估指标和多模态融合方法，支持Python与R语言工具包，实现“开箱即用”。&lt;/p>
&lt;h3 id="应用成果">应用成果&lt;/h3>
&lt;p>
&lt;figure >
&lt;div class="flex justify-center ">
&lt;div class="w-100" >&lt;img alt="TrialBench实验结果" srcset="
/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper04_hu_930050982b7f4b23.jpg 400w,
/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper04_hu_b4c2c69324fa7292.jpg 760w,
/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper04_hu_6fcc0073106c07db.jpg 1200w"
src="https://jerry-terrasse.github.io/lm_center_homepage/post/2025-10-17-trialbench-scientific-data-2025/paper04_hu_930050982b7f4b23.jpg"
width="760"
height="528"
loading="lazy" data-zoomable />&lt;/div>
&lt;/div>&lt;/figure>
&lt;/p>
&lt;p>实验结果显示，在14个二分类任务中，多模态模型在11个任务中F1分数超过0.7，展现出强大的预测能力。目前，&lt;strong>Google DeepMind&lt;/strong>已在TxGemma模型中应用TrialBench进行不良事件预测，&lt;strong>AUTOCT&lt;/strong>项目也将其作为基准评估平台。&lt;/p>
&lt;h3 id="开放获取">开放获取&lt;/h3>
&lt;p>TrialBench已向全球研究者开放，旨在推动AI与医疗研究的深度融合，助力优化临床试验设计、加速新药研发进程。&lt;/p>
&lt;p>平台链接：https://huyjj.github.io/Trialbench/&lt;/p>
&lt;p>&lt;a href="https://mp.weixin.qq.com/s/W67qpWpovmYYvTSF1hc6tA" target="_blank">查看原文&lt;/a>&lt;/p></description></item></channel></rss>